185 related articles for article (PubMed ID: 31404085)
1. Metabolomic profiling reveals salivary hypotaurine as a potential early detection marker for medication-related osteonecrosis of the jaw.
Yatsuoka W; Ueno T; Miyano K; Uezono Y; Enomoto A; Kaneko M; Ota S; Soga T; Sugimoto M; Ushijima T
PLoS One; 2019; 14(8):e0220712. PubMed ID: 31404085
[TBL] [Abstract][Full Text] [Related]
2. Salivary Biomarkers Associated With Bone Deterioration in Patients With Medication-Related Osteonecrosis of the Jaws.
Kolokythas A; Karras M; Collins E; Flick W; Miloro M; Adami G
J Oral Maxillofac Surg; 2015 Sep; 73(9):1741-7. PubMed ID: 25889372
[TBL] [Abstract][Full Text] [Related]
3. Quantitative proteomics in medication-related osteonecrosis of the jaw: A proof-of-concept study.
Lorenzo-Pouso AI; Bravo SB; Carballo J; Chantada-Vázquez MDP; Bagán J; Bagán L; Chamorro-Petronacci CM; Conde-Amboage M; López-López R; García-García A; Pérez-Sayáns M
Oral Dis; 2023 Jul; 29(5):2117-2129. PubMed ID: 35377498
[TBL] [Abstract][Full Text] [Related]
4. Osteoclastic expression of higher-level regulators NFATc1 and BCL6 in medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
Wehrhan F; Gross C; Creutzburg K; Amann K; Ries J; Kesting M; Geppert CI; Weber M
J Transl Med; 2019 Mar; 17(1):69. PubMed ID: 30832685
[TBL] [Abstract][Full Text] [Related]
5. Salivary proteomics in bisphosphonate-related osteonecrosis of the jaw.
Thumbigere-Math V; Michalowicz BS; de Jong EP; Griffin TJ; Basi DL; Hughes PJ; Tsai ML; Swenson KK; Rockwell L; Gopalakrishnan R
Oral Dis; 2015 Jan; 21(1):46-56. PubMed ID: 24286378
[TBL] [Abstract][Full Text] [Related]
6. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases.
Otto S; Pautke C; Van den Wyngaert T; Niepel D; Schiødt M
Cancer Treat Rev; 2018 Sep; 69():177-187. PubMed ID: 30055439
[TBL] [Abstract][Full Text] [Related]
7. Preventing, identifying, and managing medication-related osteonecrosis of the jaw: a practical guide for nurses and other allied healthcare professionals.
Drudge-Coates L; Van den Wyngaert T; Schiødt M; van Muilekom HAM; Demonty G; Otto S
Support Care Cancer; 2020 Sep; 28(9):4019-4029. PubMed ID: 32307659
[TBL] [Abstract][Full Text] [Related]
8. Are medication-induced salivary changes the culprit of osteonecrosis of the jaw? A systematic review.
Suryani IR; Ahmadzai I; That MT; Shujaat S; Jacobs R
Front Med (Lausanne); 2023; 10():1164051. PubMed ID: 37720502
[TBL] [Abstract][Full Text] [Related]
9. Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
Gross C; Weber M; Creutzburg K; Möbius P; Preidl R; Amann K; Wehrhan F
J Transl Med; 2017 Jun; 15(1):128. PubMed ID: 28587628
[TBL] [Abstract][Full Text] [Related]
10. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
[TBL] [Abstract][Full Text] [Related]
11. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
[TBL] [Abstract][Full Text] [Related]
12. Possible pathogenic engagement of soluble Semaphorin 4D produced by γδT cells in medication-related osteonecrosis of the jaw (MRONJ).
Movila A; Mawardi H; Nishimura K; Kiyama T; Egashira K; Kim JY; Villa A; Sasaki H; Woo SB; Kawai T
Biochem Biophys Res Commun; 2016 Nov; 480(1):42-47. PubMed ID: 27720716
[TBL] [Abstract][Full Text] [Related]
13. Meaning and Limitation of Cortical Bone Width Measurement with DentaScan in Medication-Related Osteonecrosis of the Jaws.
Iwata E; Akashi M; Kishimoto M; Kusumoto J; Hasegawa T; Furudoi S; Komori T
Kobe J Med Sci; 2017 Feb; 62(5):E114-E119. PubMed ID: 28289268
[TBL] [Abstract][Full Text] [Related]
14. Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study.
Ristow O; Rückschloß T; Müller M; Berger M; Kargus S; Pautke C; Engel M; Hoffmann J; Freudlsperger C
J Craniomaxillofac Surg; 2019 Mar; 47(3):491-499. PubMed ID: 30642734
[TBL] [Abstract][Full Text] [Related]
15. Radiographic bone loss and the risk of medication-related osteonecrosis of the jaw (MRONJ) in multiple myeloma patients-A retrospective case control study.
Wazzan T; Kashtwari D; Almaden WF; Gong Y; Chen Y; Moreb J; Katz J
Spec Care Dentist; 2018 Nov; 38(6):356-361. PubMed ID: 30194738
[TBL] [Abstract][Full Text] [Related]
16. Quantitation and distribution of metallic elements in sequestra of medication-related osteonecrosis of jaw (MRONJ) using inductively coupled plasma atomic emission spectroscopy and synchrotron radiation X-ray fluorescence analysis.
Komiya R; Wada T; Tsushima F; Sakamoto K; Ikeda T; Yamaguchi A; Harada H; Uo M
J Bone Miner Metab; 2019 Jul; 37(4):676-684. PubMed ID: 30465092
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous Healing of Mandibular Noncontinuous Defect Caused by Medication-Related Osteonecrosis of the Jaw.
Yazan M; Atil F; Kocyigit ID; Tekin U; Tuz HH; Misirlioglu M
J Craniofac Surg; 2016 Jun; 27(4):e390-2. PubMed ID: 27244207
[TBL] [Abstract][Full Text] [Related]
18. The effect of chronic dental inflammation on development of Stage 0 medication-related osteonecrosis of the jaw.
Topaloglu G; Koseoglu OT; Karaca C; Kosemehmetoglu K
J Craniomaxillofac Surg; 2017 Aug; 45(8):1158-1164. PubMed ID: 28601298
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?
Soutome S; Hayashida S; Funahara M; Sakamoto Y; Kojima Y; Yanamoto S; Umeda M
PLoS One; 2018; 13(7):e0201343. PubMed ID: 30048523
[TBL] [Abstract][Full Text] [Related]
20. "Spontaneous" medication-related osteonecrosis of the jaw; two case reports and a systematic review.
Khominsky A; Lim M
Aust Dent J; 2018 Dec; 63(4):441-454. PubMed ID: 30144095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
